Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Göbel, Maria ^a   Eisele, Lewin ^a   Möllmann, Michael ^a   Hüttmann, Andreas ^a   Johansson, Patricia ^a   Scholtysik, René ^a   Bergmann, Manuela ^b   Busch, Raymonde ^c   Döhner, Hartmut ^b   Hallek, Michael ^d   Seiler, Till ^e   Stilgenbauer, Stephan ^b   Klein Hitpass, Ludger ^a   Dührsen, Ulrich ^a   Dürig, Jan ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; PROGRANULIN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GRANULIN GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; SURVIVAL PREDICTION; SURVIVAL TIME; TIME TO TREATMENT;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882996773     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072107     Document Type: Article

References (35)

1. Dürig J, Nückel H, Hüttmann A, Kruse E, Hölter T, et al. (2003) Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. Blood 101: 2748-2755.
2. Hüttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, et al. (2006) Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 20: 1774-1782.
3. Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, et al. (2005) Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia 19: 750-758.
4. Eisele L, Prinz R, Klein-Hitpass L, Nückel H, Lowinski K, et al. (2009) Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 83: 320-327.
5. Hanoun M, Eisele L, Suzuki M, Greally JM, Hüttmann A, et al. (2012) Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 7: e34347.
6. Nückel H, Hüttmann A, Klein-Hitpass L, Schroers R, Führer A, et al. (2006) Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 47: 1053-1061.
7. Cenik B, Sephton CF, Kutluk CB, Herz J, Yu G, (2012) Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem 287: 32298-32306.
8. Toh H, Chitramuthu BP, Bennett HP, Bateman A, (2011) Structure, function, and mechanism of progranulin; the brain and beyond. J Mol Neurosci 45: 538-548.
9. Daniel R, He Z, Carmichael KP, Halper J, Bateman A, (2000) Cellular localization of gene expression for progranulin. J Histochem Cytochem 48: 999-1009.
10. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, et al. (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919.
11. Swamydas M, Nguyen D, Allen LD, Eddy J, Dreau D, (2011) Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells. Cell Commun Adhes 18: 119-130.
12. Cuevas-Antonio R, Cancino C, Arechavaleta-Velasco F, Andrade A, Barron L, et al. (2010) Expression of progranulin (Acrogranin/PCDGF/Granulin-Epithelin Precursor) in benign and malignant ovarian tumors and activation of MAPK signaling in ovarian cancer cell line. Cancer Invest 28: 452-458.
13. Ho JC, Ip YC, Cheung ST, Lee YT, Chan KF, et al. (2008) Granulin-epithelin precursor as a therapeutic target for hepatocellular carcinoma. Hepatology 47: 1524-1532.
14. Donald CD, Laddu A, Chandham P, Lim SD, Cohen C, et al. (2001) Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium. Anticancer Res 21: 3739-3742.
15. Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, et al. (2009) Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol 174: 1037-1047.
16. Wang M, Li G, Yin J, Lin T, Zhang J, (2012) Progranulin overexpression predicts overall survival in patients with glioblastoma. Med Oncol 29: 2423-2431.
17. Koo DH, Park CY, Lee ES, Ro J, Oh SW, (2012) Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study. PLoS One 7: e39880.
18. Han JJ, Yu M, Houston N, Steinberg SM, Kohn EC, (2011) Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol Oncol 120: 5-10.
19. Wang W, Hayashi J, Kim WE, Serrero G, (2003) PC cell-derived growth factor (granulin precursor) expression and action in human multiple myeloma. Clin Cancer Res 9: 2221-2228.
20. Wang W, Hayashi J, Serrero G, (2006) PC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myeloma. Clin Cancer Res 12: 49-56.
21. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, et al. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111: 5446-5456.
22. Johansson P, Eisele L, Klein-Hitpass L, Sellmann L, Dührsen U, et al. (2010) Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leuk Res 34: 892-898.
23. Frampton G, Invernizzi P, Bernuzzi F, Pae HY, Quinn M, et al. (2012) Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism. Gut 61: 268-277.
24. Li LQ, Huang HL, Ping JL, Wang XH, Zhong J, et al. (2011) Clinicopathologic and prognostic implications of progranulin in breast carcinoma. Chin Med J (Engl) 124: 2045-2050.
25. Bagnoli S, Piaceri I, Tedde A, Piacentini S, Nannucci S, et al. (2012) Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. Cell Mol Neurobiol 32: 13-16.
26. McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, et al. (2012) Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology 78: 1245-1249.
27. Antonell A, Gil S, Sanchez-Valle R, Balasa M, Bosch B, et al. (2012) Serum Progranulin Levels in Patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease: Detection of GRN Mutations in a Spanish Cohort. J Alzheimers Dis 31: 581-591.
28. Moreno C, Montserrat E, (2008) New prognostic markers in chronic lymphocytic leukemia. Blood Rev 22: 211-219.
29. Marti G, Orfao A, Goolsby C, (2006) ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue. Cytometry B Clin Cytom 70: 197-200.
30. Sivina M, Hartmann E, Kipps TJ, Rassenti L, Krupnik D, et al. (2011) CCL3 (MIP-1alpha) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood 117: 1662-1669.
31. Sellmann L, Scholtysik R, Kreuz M, Cyrull S, Tiacci E, et al. (2010) Gene dosage effects in chronic lymphocytic leukemia. Cancer Genet Cytogenet 203: 149-160.
32. Jiao J, Herl LD, Farese RV, Gao FB, (2010) MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia. PLoS One 5: e10551.
33. Calin GA, Ferracin M, Cimmino A, Di LG, Shimizu M, et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801.
34. Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, (2011) GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. BMC Cancer 11: 231.
35. Park B, Buti L, Lee S, Matsuwaki T, Spooner E, et al. (2011) Granulin is a soluble cofactor for toll-like receptor 9 signaling. Immunity 34: 505-513.